Qube Research & Technologies (QRT)
APEN

Qube Research & Technologies (QRT)’s Apollo Endosurgery, Inc. APEN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-536,288
Closed -$5.32M – 3218
2023
Q1 		$5.32M Buy
536,288
+250,248
+87% +$2.48M 0.02% 653
2022
Q4 		$2.85M Buy
+286,040
New +$2.13M 0.02% 824
2022
Q2 		– Sell
-35,766
Closed -$216K – 3299
2022
Q1 		$216K Buy
35,766
+12,185
+52% +$74.2K ﹤0.01% 1922
2021
Q4 		$199K Buy
+23,581
New +$206K ﹤0.01% 1976

Qube Research & Technologies (QRT)'s APEN Position: Q2 2023 in Review

Qube Research & Technologies (QRT) sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 536,288 shares — an estimated $5.32M sold.

Qube Research & Technologies (QRT) first reported a position in APEN in Q4 2021 and held it in 4 quarters. The position peaked at $5.32M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

  • Qube Research & Technologies (QRT) reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 536,288 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $5.32M.
  • Qube Research & Technologies (QRT) first reported a position in Apollo Endosurgery, Inc. in Q4 2021 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s Apollo Endosurgery, Inc. position peaked at $5.32M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2023, filed 14 Aug 2023.